Generic placeholder image

Current Neuropharmacology

Editor-in-Chief

ISSN (Print): 1570-159X
ISSN (Online): 1875-6190

General Review Article

Study of Nutraceuticals and Phytochemicals for the Management of Alzheimer's Disease: A Review

Author(s): Syed Sayeed Ahmad, Mohammad Khalid, Mohammad A. Kamal* and Kaiser Younis*

Volume 19, Issue 11, 2021

Published on: 15 February, 2021

Page: [1884 - 1895] Pages: 12

DOI: 10.2174/1570159X19666210215122333

Price: $65

Open Access Journals Promotions 2
Abstract

Background: Alzheimer's disease (AD) affects several people worldwide and has devastating impacts on society with a limited number of approaches for its pharmacological treatment. The main causes of AD are not clear yet. However, the formation of senile plaques, neurofibrillary tangles, hyper-phosphorylation of tau protein, and disruption of redox homeostasis may cause AD. These causes have a positive correlation with oxidative stress, producing reactive ions, which are responsible for altering the physiological condition of the body.

Conclusion: Ongoing research recommended the use of phytochemicals as acetylcholinesterase inhibitors to hinder the onset and progression of AD. The natural compound structures, including lignans, flavonoids, tannins, polyphenols, triterpenes, sterols, and alkaloids have anti-inflammatory, antioxidant, and anti-amyloidogenic properties. The purpose of this article is to provide a brief introduction to AD along with the use of natural compounds as new therapeutic approaches for its management.

Keywords: Alzheimer's disease, nutraceuticals, nutrients, phytochemicals, mechanism of AChE in Alzheimer's disease.

Graphical Abstract

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy